On March 2, 2015, Dr. Andrew Mearns Spragg, General Manager of Jellagen, a medical technology company in the United Kingdom, and Ecz. Selçuk Haydanlı visited TÜBİTAK MAM KE in order to develop a joint project within the scope of EU Horizon 2020. Within the scope of the visit, Dr. Serdar Sezer, Deputy Director of TÜBİTAK MAM KE Institute, provided information about the projects carried out/planned in the medical field and the EU Horizon 2020 calls with private sector participation. Following the presentations of the projects open to possible cooperation, the company representatives visited TÜBİTAK MAM KE laboratories and received information about the relevant studies.
Share this News
For questions and suggestionsContact Us
Most Recent
TÜBİTAK MAM, Türkiye Plastik Atık Çalıştayı’nda Bilimsel ve Teknolojik Yetkinliklerini Ortaya Koydu
TÜBİTAK MAM, plastik atıkların çevresel, ekonomik ve insan sağlığına yönelik boyutlarının ele alındığı Türkiye Plastik Atık Çalıştayı’nda, farklı disiplinlerdeki bilimsel...
TÜBİTAK Marmara Research Center (MAM) Will Be Hiring Both Experienced and Inexperienced Staff
TÜBİTAK Marmara Research Center (MAM) will be hiring both experienced and inexperienced staff to be employed at the center. Job postings numbered TBTK.MAM.A.2026-1, TBTK.MAM.A.2026-2, and TBTK.MAM.T.2026-1...
The Evaluation Process for Job Posting No. TBTK.MAM.2026.ADAY-1 Has Been Completed
The evaluation process for applications submitted for our job posting No. TBTK.MAM.2026.ADAY-1 has been completed, and the candidates eligible for the interview have been selected. You can view the results of your application. The interview schedule,...
The SciREACT Project's Closing Conference Was Held
At the closing conference of the SciREACT Project, coordinated by TÜBİTAK MAM, the project’s concrete outcomes and the Pandemic-X Workshop report were presented. The Ministry of Industry and Technology...